The Effect of Sleep Apnea and Hypertension on Gut Microbiome
Gut Microbiome Characteristics in the Human Cohort With OSA/Hypertension
1 other identifier
observational
52
1 country
1
Brief Summary
Obstructive sleep apnea (OSA) and hypertension are closely associated diseases. Here we characterized the differences in the gut microbiome which is affected by the two diseases, when the two diseases coexist or are present alone. Fifty-two consecutive patients who underwent polysomnography (PSG) were enrolled and divided into four groups: without OSA or hypertension (OSA0HT0), OSA without hypertension (OSA1HT0), hypertension without OSA (OSA0HT1), and with OSA and hypertension (OSA1HT1). Fecal specimens were collected for 16S rRNA sequencing and the characteristics of community richness, diversity, and composition of the gut microbiome and their relationship with disease were analyzed using bioinformatics methods.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jul 2017
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 30, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
May 28, 2018
CompletedFirst Submitted
Initial submission to the registry
February 1, 2022
CompletedFirst Posted
Study publicly available on registry
March 4, 2022
CompletedOctober 22, 2024
October 1, 2024
5 months
February 1, 2022
October 21, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
1. Comparisons of the relative community richness of Clostridia of the gut microbiota in OSA0HT0,OSA0HT1,OSA1HT0 and OSA1HT1 group.
from July 2017 to November 2017
Secondary Outcomes (3)
2. Comparison of the overall community diversity of the gut microbiome in OSA0HT0,OSA0HT1,OSA1HT0 and OSA1H1 group.
from July 2017 to November 2017
3. Comparison of the overall community richness of the gut microbiome in OSA0HT0,OSA0HT1,OSA1HT0 and OSA1H1 group.
from July 2017 to November 2017
4. Relationship between alpha diversity of the gut microbiome and hypoxia burden of PSG study.
from July 2017 to November 2017
Study Arms (4)
OSA0HT0
without OSA or hypertension (OSA0HT0)
OSA1HT0
OSA without hypertension (OSA1HT0)
OSA0HT1
hypertension without OSA (OSA0HT1)
OSA1HT1
with OSA and hypertension (OSA1HT1)
Eligibility Criteria
Participants were divided into four groups according to whether they had a confirmed diagnosis of essential HT and OSA (AHI ≥15 beats/h (International Classification of Sleep Disorders (3rd edition) ), as follows. Individuals without OSA and HT belonged to group OSA0HT0; individuals with both OSA and HT were in group OSA1HT1; individuals without OSA but with HT were in group OSA0HT1; and individuals with OSA but without HT were in the group OSA1HT0.
You may qualify if:
- age 18 years or older
- outpatients and inpatients who underwent a PSG study for snoring
- those who volunteered for this study and signed an informed consent form
You may not qualify if:
- patients who were treated for OSA (regular CPAP therapy, oral appliances, maxillofacial surgery, etc.) prior to enrolment
- patients with secondary HT with a clear primary cause
- those with a history of dyspeptic disease (history of gastrointestinal surgery, peptic ulcer, inflammatory bowel disease, chronic pancreatitis, etc.)
- those who had organ insufficiency, were receiving immune agents or glucose
- those who had received antibiotic treatment in the last 2 months or had taken probiotic products (yogurt, milk, cheese, etc.) continuously (daily) for the last 2 months
- Alcohol or drug dependency
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Peking University First Hospital
Beijing, Beijing Municipality, 100034, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
February 1, 2022
First Posted
March 4, 2022
Study Start
July 1, 2017
Primary Completion
November 30, 2017
Study Completion
May 28, 2018
Last Updated
October 22, 2024
Record last verified: 2024-10